These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22396548)

  • 1. Intestinal expression of mouse Abcg2/breast cancer resistance protein (BCRP) gene is under control of circadian clock-activating transcription factor-4 pathway.
    Hamdan AM; Koyanagi S; Wada E; Kusunose N; Murakami Y; Matsunaga N; Ohdo S
    J Biol Chem; 2012 May; 287(21):17224-17231. PubMed ID: 22396548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestine.
    Natarajan K; Xie Y; Nakanishi T; Beck WT; Bauer KS; Ross DD
    Biochim Biophys Acta; 2011 Jul; 1809(7):295-305. PubMed ID: 21718815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cAMP-response element (CRE)-mediated transcription by activating transcription factor-4 (ATF4) is essential for circadian expression of the Period2 gene.
    Koyanagi S; Hamdan AM; Horiguchi M; Kusunose N; Okamoto A; Matsunaga N; Ohdo S
    J Biol Chem; 2011 Sep; 286(37):32416-23. PubMed ID: 21768648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model.
    Dallas S; Salphati L; Gomez-Zepeda D; Wanek T; Chen L; Chu X; Kunta J; Mezler M; Menet MC; Chasseigneaux S; Declèves X; Langer O; Pierre E; DiLoreto K; Hoft C; Laplanche L; Pang J; Pereira T; Andonian C; Simic D; Rode A; Yabut J; Zhang X; Scheer N
    Mol Pharmacol; 2016 May; 89(5):492-504. PubMed ID: 26893303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of mouse Abcg2 mRNA during hematopoiesis is regulated by alternative use of multiple leader exons and promoters.
    Zong Y; Zhou S; Fatima S; Sorrentino BP
    J Biol Chem; 2006 Oct; 281(40):29625-32. PubMed ID: 16885162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel xenobiotic responsive element regulated by aryl hydrocarbon receptor is involved in the induction of BCRP/ABCG2 in LS174T cells.
    Tompkins LM; Li H; Li L; Lynch C; Xie Y; Nakanishi T; Ross DD; Wang H
    Biochem Pharmacol; 2010 Dec; 80(11):1754-61. PubMed ID: 20804740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.
    Hoque MT; Shah A; More V; Miller DS; Bendayan R
    J Neurochem; 2015 Dec; 135(6):1113-22. PubMed ID: 26465636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers.
    Taipalensuu J; Törnblom H; Lindberg G; Einarsson C; Sjöqvist F; Melhus H; Garberg P; Sjöström B; Lundgren B; Artursson P
    J Pharmacol Exp Ther; 2001 Oct; 299(1):164-70. PubMed ID: 11561076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse.
    Zaher H; Khan AA; Palandra J; Brayman TG; Yu L; Ware JA
    Mol Pharm; 2006; 3(1):55-61. PubMed ID: 16686369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of the oral drug absorption of topotecan through the inhibition of intestinal xenobiotic efflux transporter, breast cancer resistance protein, by excipients.
    Yamagata T; Kusuhara H; Morishita M; Takayama K; Benameur H; Sugiyama Y
    Drug Metab Dispos; 2007 Jul; 35(7):1142-8. PubMed ID: 17446265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe.
    Urquhart BL; Ware JA; Tirona RG; Ho RH; Leake BF; Schwarz UI; Zaher H; Palandra J; Gregor JC; Dresser GK; Kim RB
    Pharmacogenet Genomics; 2008 May; 18(5):439-48. PubMed ID: 18408567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.
    Nakanishi T; Ross DD
    Chin J Cancer; 2012 Feb; 31(2):73-99. PubMed ID: 22098950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the breast cancer resistance protein (ABCG2) in drug transport.
    Mao Q; Unadkat JD
    AAPS J; 2005 May; 7(1):E118-33. PubMed ID: 16146333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.
    Xie Y; Nakanishi T; Natarajan K; Safren L; Hamburger AW; Hussain A; Ross DD
    Biochim Biophys Acta; 2015 Mar; 1849(3):317-27. PubMed ID: 25615818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage.
    Nakanishi T; Bailey-Dell KJ; Hassel BA; Shiozawa K; Sullivan DM; Turner J; Ross DD
    Cancer Res; 2006 May; 66(10):5007-11. PubMed ID: 16707421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2).
    Tan KP; Wang B; Yang M; Boutros PC; Macaulay J; Xu H; Chuang AI; Kosuge K; Yamamoto M; Takahashi S; Wu AM; Ross DD; Harper PA; Ito S
    Mol Pharmacol; 2010 Aug; 78(2):175-85. PubMed ID: 20460431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating drug resistance by targeting BCRP/ABCG2 using retrovirus-mediated RNA interference.
    Xie N; Mou L; Yuan J; Liu W; Deng T; Li Z; Jing Y; Hu Z
    PLoS One; 2014; 9(7):e103463. PubMed ID: 25076217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.
    Zamber CP; Lamba JK; Yasuda K; Farnum J; Thummel K; Schuetz JD; Schuetz EG
    Pharmacogenetics; 2003 Jan; 13(1):19-28. PubMed ID: 12544509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal breast cancer resistance protein (BCRP) requires Janus kinase 3 activity for drug efflux and barrier functions in obesity.
    Mishra J; Simonsen R; Kumar N
    J Biol Chem; 2019 Nov; 294(48):18337-18348. PubMed ID: 31653704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleic acid increases intestinal absorption of the BCRP/ABCG2 substrate, mitoxantrone, in mice.
    Aspenström-Fagerlund B; Tallkvist J; Ilbäck NG; Glynn AW
    Toxicol Lett; 2015 Sep; 237(2):133-9. PubMed ID: 26071310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.